pharma news today glp-1 Drugs: The Science and the Scarcity People using popular weight-loss drugs
Description
End-Users 16.5
Currently, the American Society of Anesthesiologists recommends holding GLP-1 RAs on the day of the procedure to mitigate risks associated with delayed gastric emptying, such as aspiration [9]
Given the vast number of incretin-based medications under development, mainly aiming at higher efficacy in body weight reduction, one may overlook that adherence to, and persistence of, therapy with GLP-1RAs in real-world studies is relatively low (18, 126)
2022LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept
29 Johnson, N.P., Metformin use in women with polycystic ovary syndrome
Thermogenic mechanisms in brown fat
